San Antonio, TX – Adaptivo™ stole the show at ASTRO Annual Meeting 2015. With unmatched adaptive patient dosimetry capabilities, this software product reinforced Standard Imaging’s medical physics leadership and vision.

“It was truly thrilling to see interest and excitement with Adaptivo™”, said Ed Neumueller, president & CEO of Standard Imaging. “Adaptivo™’s ability to improve patient treatment was something we couldn’t wait to unveil to medical professionals around the world—and the response was extraordinary. Adaptivo™ will certainly be a platform for future applications and advancements for our customers.”

Adaptivo™ is a truly unique software that provides a complete picture of the patient and dose at each stage of treatment—empowering clinics to improve treatment outcomes and reimbursement. The unique use of CBCT for daily and cumulative dose, rather than logfiles, provides accurate dose tracking, allowing important treatment decisions to be made. These capabilities of Adaptivo™ immediately antiquate other patient dosimetry solutions.

This software was demonstrated at Standard Imaging’s booth during ASTRO.

Learn More

ASTRO's Annual Meeting is the premier radiation oncology scientific event in the world and draws more than 11,000 attendees each year. [via astro.org]

Standard Imaging is a leading manufacturer of radiation calibration and quality assurance instruments for healthcare. The company was founded in 1989, and has become a leader in the medical physics field. As a company with many products aimed at supporting radiation therapy for cancer treatment, Standard Imaging is committed to the fight against cancer. For more information, visit www.standardimaging.com or contact Standard Imaging at 608-831-0025.